These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 25703954)
1. Nanoparticles for controlled delivery and sustained release of chlorhexidine in the oral environment. Garner S; Barbour ME Oral Dis; 2015 Jul; 21(5):641-4. PubMed ID: 25703954 [TBL] [Abstract][Full Text] [Related]
2. Chlorhexidine hexametaphosphate nanoparticles as a novel antimicrobial coating for dental implants. Wood NJ; Jenkinson HF; Davis SA; Mann S; O'Sullivan DJ; Barbour ME J Mater Sci Mater Med; 2015 Jun; 26(6):201. PubMed ID: 26123234 [TBL] [Abstract][Full Text] [Related]
3. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease. Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products. Barbour ME; Maddocks SE; Wood NJ; Collins AM Int J Nanomedicine; 2013; 8():3507-19. PubMed ID: 24092973 [TBL] [Abstract][Full Text] [Related]
6. Transient reduction of mutans streptococci on tooth surfaces using a chlorhexidine-containing glass ionomer cement varnish. Hoszek A; Ericson D Swed Dent J; 1999; 23(2-3):97-105. PubMed ID: 10431345 [TBL] [Abstract][Full Text] [Related]
7. Development of a novel antimicrobial-releasing glass ionomer cement functionalized with chlorhexidine hexametaphosphate nanoparticles. Hook ER; Owen OJ; Bellis CA; Holder JA; O'Sullivan DJ; Barbour ME J Nanobiotechnology; 2014 Jan; 12():3. PubMed ID: 24456793 [TBL] [Abstract][Full Text] [Related]
8. Glass ionomer cements with milled, dry chlorhexidine hexametaphosphate filler particles to provide long-term antimicrobial properties with recharge capacity. Bellis CA; Addison O; Nobbs AH; Duckworth PF; Holder JA; Barbour ME Dent Mater; 2018 Dec; 34(12):1717-1726. PubMed ID: 30249499 [TBL] [Abstract][Full Text] [Related]
9. Adsorption of chlorhexidine on synthetic hydroxyapatite and in vitro biological activity. de Souza CA; Colombo AP; Souto RM; Silva-Boghossian CM; Granjeiro JM; Alves GG; Rossi AM; Rocha-Leão MH Colloids Surf B Biointerfaces; 2011 Oct; 87(2):310-8. PubMed ID: 21676601 [TBL] [Abstract][Full Text] [Related]
10. An antifungal coating for dental silicones composed of chlorhexidine nanoparticles. Garner SJ; Nobbs AH; McNally LM; Barbour ME J Dent; 2015 Mar; 43(3):362-72. PubMed ID: 25511302 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial substantivity of bovine root dentin exposed to different chlorhexidine delivery vehicles. Lenet BJ; Komorowski R; Wu XY; Huang J; Grad H; Lawrence HP; Friedman S J Endod; 2000 Nov; 26(11):652-5. PubMed ID: 11469294 [TBL] [Abstract][Full Text] [Related]
12. Functionalization of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles. Wood NJ; Maddocks SE; Grady HJ; Collins AM; Barbour ME Int J Nanomedicine; 2014; 9():4145-52. PubMed ID: 25206305 [TBL] [Abstract][Full Text] [Related]
13. [Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial]. Koeman M; van der Ven AJ; Hak E; Joore JC; Kaasjager HA; de Smet AM; Ramsay G; Dormans TP; Aarts LP; de Bel EE; Hustinx WN; van der Tweel I; Hoepelman IM; Bonten MJ Ned Tijdschr Geneeskd; 2008 Mar; 152(13):752-9. PubMed ID: 18461894 [TBL] [Abstract][Full Text] [Related]
14. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Koeman M; van der Ven AJ; Hak E; Joore HC; Kaasjager K; de Smet AG; Ramsay G; Dormans TP; Aarts LP; de Bel EE; Hustinx WN; van der Tweel I; Hoepelman AM; Bonten MJ Am J Respir Crit Care Med; 2006 Jun; 173(12):1348-55. PubMed ID: 16603609 [TBL] [Abstract][Full Text] [Related]
15. Sustained ex vivo skin antiseptic activity of chlorhexidine in poly(epsilon-caprolactone) nanocapsule encapsulated form and as a digluconate. Lboutounne H; Chaulet JF; Ploton C; Falson F; Pirot F J Control Release; 2002 Aug; 82(2-3):319-34. PubMed ID: 12175746 [TBL] [Abstract][Full Text] [Related]
16. Chlorhexidine controlled-release profile after EDTA root surface etching: an in vivo study. Gamal AY; Kumper RM; Sadek HS; El Destawy MT J Periodontol; 2011 May; 82(5):751-7. PubMed ID: 21091349 [TBL] [Abstract][Full Text] [Related]
17. Alginate films augmented with chlorhexidine hexametaphosphate particles provide sustained antimicrobial properties for application in wound care. Duckworth PF; Maddocks SE; Rahatekar SS; Barbour ME J Mater Sci Mater Med; 2020 Mar; 31(3):33. PubMed ID: 32162052 [TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiologic effects of subgingival controlled-release delivery of chlorhexidine chip in the treatment of periodontitis: a multicenter study. Paolantonio M; D'Angelo M; Grassi RF; Perinetti G; Piccolomini R; Pizzo G; Annunziata M; D'Archivio D; D'Ercole S; Nardi G; Guida L J Periodontol; 2008 Feb; 79(2):271-82. PubMed ID: 18251641 [TBL] [Abstract][Full Text] [Related]
19. Chlorhexidine hexametaphosphate as a coating for elastomeric ligatures with sustained antimicrobial properties: A laboratory study. Kamarudin Y; Skeats MK; Ireland AJ; Barbour ME Am J Orthod Dentofacial Orthop; 2020 Nov; 158(5):e73-e82. PubMed ID: 33008710 [TBL] [Abstract][Full Text] [Related]
20. The effect of subgingival controlled-release delivery of chlorhexidine chip on clinical parameters and matrix metalloproteinase-8 levels in gingival crevicular fluid. Azmak N; Atilla G; Luoto H; Sorsa T J Periodontol; 2002 Jun; 73(6):608-15. PubMed ID: 12083533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]